Baudax Bio, Inc. (BXRXQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Oct 30, 16:00
Baudax Bio Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | -1.674 |
| June 30, 2023 | -1.668 |
| March 31, 2023 | -1.016 |
| December 31, 2022 | -0.2937 |
| September 30, 2022 | -0.446 |
| June 30, 2022 | 2.208 |
| March 31, 2022 | 0.9638 |
| December 31, 2021 | 0.6942 |
| September 30, 2021 | -0.4397 |
| June 30, 2021 | -1.818 |
| Date | Value |
|---|---|
| March 31, 2021 | -9.680 |
| December 31, 2020 | -0.6607 |
| September 30, 2020 | -0.2053 |
| June 30, 2020 | -0.1563 |
| March 31, 2020 | -0.0186 |
| December 31, 2019 | -0.0462 |
| September 30, 2019 | -0.0247 |
| June 30, 2019 | -0.0338 |
| March 31, 2019 | -0.0214 |
| December 31, 2018 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5477 |
| Eli Lilly & Co. | 1.229 |